KRT19 and breast cancer: The OSNA test analyses genetic material from solubilised SLNB biopsy samples [15] and detects the presence of the cytokeratin-19 (CK19) gene, a marker associated with breast cancer—and will provide a result within a short time, enabling surgeons to determine whether other lymph nodes should be removed at the same time.